The Results of Phase II Clinical Study of KN046 in Combination with Nab-paclitaxel in TNBC were Published in Nature Communications
SUZHOU, China, Feb. 6, 2024 /PRNewswire/ — Alpham […]
News from PR Newswire
SUZHOU, China, Feb. 6, 2024 /PRNewswire/ — Alpham […]
ZTE has been recognized for its outstanding actions aga […]
SINGAPORE, Feb. 7, 2024 /PRNewswire/ — A disrupti […]
SYDNEY, Feb. 7, 2024 /PRNewswire/ — Specialist cl […]
Latest research from Pattern reveals current Australian […]
Announcement Made at End of Week-Long European Event in […]
SHANGHAI, Feb. 7, 2024 /PRNewswire/ — UnionPay In […]
HONG KONG, Feb. 7, 2024 /PRNewswire/ — NOIZ GROUP […]
LG Will Sell Washers and Dryers to America’s Lead […]
HONG KONG, Feb. 6, 2024 /PRNewswire/ — bolttech I […]
Advancing development of EUV photomasks for IBM’s […]
SYDNEY, Feb. 7, 2024 /PRNewswire/ — Global softwa […]